Intuitive Surgical’s (ISRG) Buy Rating Reaffirmed at Goldman Sachs Group, Inc. (The)
Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “buy” rating reissued by investment analysts at Goldman Sachs Group, Inc. (The) in a research report issued to clients and investors on Saturday.
Several other equities research analysts also recently issued reports on ISRG. Vetr downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 price objective for the company. in a research note on Wednesday, August 16th. Royal Bank Of Canada reiterated a “hold” rating and set a $111.11 price objective on shares of Intuitive Surgical in a research note on Friday, July 21st. Citigroup Inc. reiterated a “buy” rating and set a $119.78 price objective (up from $101.89) on shares of Intuitive Surgical in a research note on Monday, July 24th. Wells Fargo & Company reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Monday, October 16th. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $116.67 price objective on shares of Intuitive Surgical in a research note on Friday, July 21st. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Intuitive Surgical has a consensus rating of “Buy” and a consensus price target of $155.78.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at $392.48 on Friday. Intuitive Surgical has a twelve month low of $203.57 and a twelve month high of $400.00. The stock has a market cap of $43,976.60, a P/E ratio of 51.94, a P/E/G ratio of 5.45 and a beta of 0.47.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.78. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.20%. The firm had revenue of $806.10 million during the quarter, compared to the consensus estimate of $753.25 million. During the same period in the previous year, the firm earned $2.06 earnings per share. Intuitive Surgical’s revenue was up 18.0% compared to the same quarter last year. analysts forecast that Intuitive Surgical will post 7.85 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical’s (ISRG) Buy Rating Reaffirmed at Goldman Sachs Group, Inc. (The)” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/11/19/intuitive-surgicals-isrg-buy-rating-reaffirmed-at-goldman-sachs-group-inc-the.html.
In related news, EVP Salvatore Brogna sold 899 shares of the company’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $1,001.90, for a total value of $900,708.10. Following the sale, the executive vice president now directly owns 570 shares of the company’s stock, valued at $571,083. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark J. Meltzer sold 500 shares of the company’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $982.90, for a total transaction of $491,450.00. Following the completion of the sale, the senior vice president now directly owns 2,796 shares in the company, valued at $2,748,188.40. The disclosure for this sale can be found here. Insiders sold 36,656 shares of company stock worth $15,432,702 over the last ninety days. 2.20% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently bought and sold shares of the stock. ETF Managers Group LLC acquired a new stake in Intuitive Surgical in the second quarter valued at $110,000. Harvest Fund Management Co. Ltd acquired a new stake in Intuitive Surgical in the second quarter valued at $120,000. Parallel Advisors LLC raised its holdings in Intuitive Surgical by 3.9% in the second quarter. Parallel Advisors LLC now owns 159 shares of the medical equipment provider’s stock valued at $149,000 after acquiring an additional 6 shares in the last quarter. Lincoln National Corp acquired a new stake in Intuitive Surgical in the third quarter valued at $200,000. Finally, MUFG Americas Holdings Corp acquired a new stake in Intuitive Surgical in the third quarter valued at $208,000. 31.30% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.